“Terminally ill patients have a constitutional right to obtain experimental drugs before the Food and Drug Administration has decided whether to approve them, a federal appeals court ruled yesterday,” reports the Washington Post. Instant reaction: Right policy, wrong branch of government. CEI makes some good points in defense of the ruling.